back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-27 19:05 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$41,050
+6,516 vol $6.30 each |
15,475 | |
| Filed 2026-03-27 19:03 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$41,050
+6,516 vol $6.30 each |
15,475 | |
| Filed 2026-03-27 18:58 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,216
+7,522 vol $6.41 each |
14,548 | |
| Filed 2026-03-27 18:56 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-24,871.25
-4,925 vol $5.05 each |
8,959 | |
| Filed 2026-03-27 18:53 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-24,871.25
-4,925 vol $5.05 each |
8,959 | |
| Filed 2026-03-20 15:47 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,182
+1,002 vol $6.17 each |
7,026 | |
| Filed 2025-12-19 14:38 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,277
+1,041 vol $6.03 each |
6,024 | |
| Filed 2025-09-17 16:06 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,172
+966 vol $6.39 each |
4,983 | |
| Filed 2025-08-14 09:36 Tx date 2025-08-06 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$1,778
+286 vol $6.22 each |
13,884 | |
| Filed 2025-08-14 09:32 Tx date 2025-08-06 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$1,778
+286 vol $6.22 each |
13,884 | |
| Filed 2025-06-18 16:38 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,270
+707 vol $6.04 each |
4,017 | |
| Filed 2025-06-17 16:16 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$29,398
+4,734 vol $6.21 each |
13,598 | |
| Filed 2025-06-17 16:12 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$29,398
+4,734 vol $6.21 each |
13,598 | |
| Filed 2025-03-29 16:40 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,256
+3,906 vol $6.21 each |
||
| Filed 2025-03-29 16:39 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,256
+3,906 vol $6.21 each |
||
| Filed 2025-03-29 16:40 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,256
+3,906 vol $6.21 each |
12,770 | |
| Filed 2025-03-29 16:39 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,256
+3,906 vol $6.21 each |
12,770 | |
| Filed 2025-03-20 15:57 Tx date 2025-03-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,440
+1,077 vol $5.98 each |
3,310 | |
| Filed 2024-12-18 12:24 Tx date 2024-12-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,207
+803 vol $5.24 each |
2,233 | |
| Filed 2024-09-18 14:21 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,189
+710 vol $5.90 each |
1,430 |